(1)
Rahman, A.; Azra, F. DOCKING SIMULATION OF 1,2,3-TRIAZOLO-INDOLE-2-CARBOXYLATE DERIVATIVES AS POTENTIAL HER2 INHIBITORS FOR BREAST CANCER THERAPY. JC 2026, 8, 273-287.